About this trial
The objective of this observational study is to evaluate the diagnostic effectiveness of magnetocardiography (MCG) in patients with stable coronary artery disease (SCAD) and compare it with coronary CTA (CCTA). Additionally, the study aims to determine the most suitable diagnostic index for MCG. The primary question it seeks to address is whether MCG or MCG combined with CCTA can be utilized to guide the clinical application of percutaneous coronary intervention (PCI) for coronary heart disease.
Eligibility criteria
Qualifiers
Age ≥18 years old.
Stable coronary artery disease patients with a coronary CTA stenosis degree of 30% to 90%.
Sign informed consent.
Disqualifiers
Patients diagnosed with acute coronary syndrome.
Patients diagnosed with hypertrophic cardiomyopathy.
Patients diagnosed with dilated cardiomyopathy.
Patients with complex arrhythmias, such as frequent atrial premature beats, ventricular premature beats, and complete bundle branch block.
Trial design
Treatments tested in this trial
- Not listed